Thursday, 5 November 2026European Markets

XXL Stock Soars 34% In 5 Sessions: Is It Time To Buy?

Loading stream...
(VIANEWS) - Shares of XXL (XXL.OL) have experienced an extraordinary 34.86% gain over five trading sessions from kr0.7 to kr0.94 at 14:53 EST on Friday - following two consecutive sessions of gains. Meanwhile, the Oslo Bors Benchmark Index_GI has rebounded with gains of 0.44% at 1,328.15 after experiencing losses during previous session's decline; closing price for XXL at this level 54.97% below its 52-week high of Kr2.09

About XXL

XXL ASA is an international sports and outdoor retailer established in 2000 in Oslo, Norway. They currently have stores located throughout Norway, Sweden and Finland as well as an e-commerce website in these three countries and xxl.dk that offer products related to various sporting activities - as well as hunting products that cater specifically to this sector of activities. Furthermore, high-end and everyday bikes as well as bike equipment is offered through them along with products that marry technology with sports/outdoor activities can all be found here!

Yearly Analysis

Yearly Peak and Bottom Values: The current stock value of XXL stands at kr0.94, significantly less than its 52-week high of 2.09 but higher than its 52-week low of 0.57 indicating some recent recovery for the stock. Anticipated Sales Growth: According to available information, XXL anticipates sales growth at 9.9% this year and 5.3% next year - this indicates a steady pace of sales expansion over the coming years. Earnings Before Interest, Taxes, Depreciation and Amortization (EBITDA): The Earnings Before Interest Tax Depreciation and Amortization (EBITDA) figure for XXL stands at 118.56; this indicates its profitability by showing that a high EBITDA number indicates significant profits despite interest expenses, taxes payments, depreciation costs and amortization expenses. Overall, XXL stock value is lower than its 52-week high but higher than its 52-week low. Anticipated sales growth for the company is moderate while EBITDA positive and profitable indicating profitability; however this analysis only considers limited data and investors should conduct further investigation prior to making any investment decisions based on this analysis.

Technical Analysis

XXL stock has recently shown signs of potential revival as its current value sits above both its 50-day and 200-day moving averages of kr0.93, signalling an upward trend both short- and long-term. Furthermore, its last reported volume (38504362) significantly outstripped its average volume (5335040), suggesting increased interest for this stock. Note, however, that XXL's volatility has been relatively high over the past week or month with average intraday variations of 5.59%, 0.88%, and 4.42%; highest average weekly volatility being 7.29%; monthly average was 4.67% with quarterly averages 4.42% and 4.45%. Technically speaking, the stochastic oscillator has classified XXL's stock as oversold (=20), which may represent an opportunity to invest. Before making any definitive investment decisions or investments decisions based on this signal alone. Investors should remember that stock prices can be affected by various economic and political events as well as company news or market sentiment - therefore keeping an eye on all possible factors can help guide investment decisions more successfully.

Quarter Analysis

XXL has experienced strong sales growth this quarter while year-on-year revenue growth has fallen slightly; additionally, they provided growth estimates which range between 50-70% for this quarter and next. Before making any investment decisions, investors should carefully consider this information along with other relevant factors. Additional research may help investors gain a more in-depth understanding of XXL's financial performance, industry trends and any other relevant factors which could provide them with insights into its prospects and risks.

Equity Analysis

According to the information available, XXL reported a negative return on equity of -60.25% over twelve trailing months, suggesting it has not generated profits for its shareholders and may not be using its equity efficiently to generate profits. Furthermore, this company reported an EPS loss per share over this timeframe of kr-2.35; investors should carefully consider this data and conduct further investigation of this company before making investment decisions based on it. More news about XXL (XXL.OL).
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Oncology Data Season and Biotech Capital Allocation: ESMO Readouts, Ivonescimab PDUFA, and Diverging Corporate Moves
Late-2026 biotech is driven by a dense catalyst calendar. ESMO 2026 delivers data from ivonescimab, Enhertu, R-DXd and bemarituzumab, and the FDA has set a 14 Nov PDUFA date for the ivonescimab BLA. Capital allocation is diverging. Krystal Biotech authorized a $400M buyback while lowering FY2026 spend guidance and pushing milestones into 2027. Spago is moving to delist from Nasdaq First North. The facts are clinical and corporate events, not AI or fintech, so the finance angle is limited to capital markets (buybacks, guidance, delistings, regulatory timelines).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,549 source documents archived
Query this data → isubstrate.com